Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and

Cathy D Vocke1, Christopher J Ricketts1, Adam R Metwalli1

  • 1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Urology
|April 26, 2022
PubMed
Abstract

Insights

VHL gene mutation analysis can distinguish between independent kidney tumors and metastasis in clear cell renal cell carcinoma (ccRCC) patients. This genetic testing improves diagnosis and management for multifocal ccRCC.

Area of Science:

  • Oncology
  • Genetics
  • Nephrology

Background:

  • The origin of multifocal clear cell renal cell carcinoma (ccRCC) is often unclear, especially outside of hereditary syndromes.
  • Distinguishing between independent primary tumors and metastatic spread is crucial for patient management.

Purpose of the Study:

  • To determine if VHL gene mutation analysis can differentiate bilateral, multifocal ccRCC into independent primaries versus metastatic disease.
  • To assess the utility of genetic testing in understanding ccRCC multifocality.

Main Methods:

  • Somatic VHL gene mutation and hypermethylation analysis were performed on multiple tumors from ccRCC patients.
  • Targeted next-generation sequencing was used for tumors with shared VHL mutations.

Main Results:

  • Five patients showed shared VHL mutations, indicating metastatic spread, often confirmed by additional shared mutations.
  • Fourteen patients had unique VHL alterations in each tumor, consistent with independent primary tumors and no evidence of spread.

Conclusions:

  • VHL gene alterations can reliably distinguish between metastatic ccRCC and independently arising multifocal tumors.
  • This genetic analysis, using standard clinical tests, enhances diagnostic accuracy, prognosis, and treatment strategies for ccRCC.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...